The federal contract award is for the delivery of Dronabinol 2.5 mg capsules to the Defense Logistics Agency (DLA). The $3,333.66 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 7, 2024, with a completion date of November 8, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and veterans' healthcare systems.
Generated 2/6/25, 9:30 AM